Medisinsk forskning på cannabis
I dette arkivet finner du over 15 000 lenker til forskningsartikler og studier på cannabis planten. Listen er på engelsk, delt opp i medisinske lidelser og andre kategorier i alfabetisk rekkefølge.
NB! Sidene på hver bokstav kan laste tregt da tusenvis av linker lastes
D
DEPRESSION (158)
-
The use of Cannnabidiol (CBD) to Reduce Insomnia and the Urge To Use Alcohol in a Geriatric person in on going Behavior Therapy
-
The use of Cannnabidiol (CBD) and Meditation to reduce Binge Drinking, Anxiety and to improve Emotional Regulation in Long Term Behavior Therapy
-
Mixed mood disorder
-
Harm Reduction: Alcohol Use Disorder, Cannabis-induced Psychotic Disorder and a tale of two Hemp Oils, in a Patient diagnosed with a Cluster A & B Personality Disorders in Long Term Behavior Therapy
-
Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L
-
Uni-Morbid and Co-Occurring Marijuana and Tobacco Use: Examination of Concurrent Associations with Negative Mood States
-
Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders?
-
Deficiency in Endocannabinoid Signaling in the Nucleus Accumbens Induced by Chronic Unpredictable Stress
-
Depression-resistant endophenotype in mice overexpressing cannabinoid CB2 receptors
-
The Potential Role of Cannabinoids in Modulating Serotonergic Signaling by Their Influence on Tryptophan Metabolism
-
Brain CB2 Receptors: Implications for Neuropsychiatric Disorders
-
Genes differentially expressed in CB1 knockout mice: involvement in the depressive-like phenotype
-
Gadolinium-HU-308-incorporated micelles
-
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
-
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress
-
N-palmitoylethanolamide, an endocannabinoid, exhibits antidepressant effects in the forced swim test and the tail suspension test in mice
-
Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions
-
Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Figure 1: n-3/n-6 PUFA dietary imbalance alters PUFAs level in mouse brain
-
Endocannabinoid system dysfunction in mood and related disorders
-
Intense exercise increases circulating endocannabinoid and BDNF levels in humansâPossible implications for reward and depression
-
Personalized medicine can pave the way for the safe use of CBâ receptor antagonists
-
Cannabinoids and emotionality: a neuroanatomical perspective
-
Testing bidirectional effects between cannabis use and depressive symptoms: moderation by the serotonin transporter gene
-
High on Life? Medical Marijuana Laws and Suicide
-
Serum contents of endocannabinoids are correlated with blood pressure in depressed women
-
Cannabis use and depression: a longitudinal study of a national cohort of Swedish conscripts
-
Cannabinoid Receptor Genotype Moderation of the Effects of Childhood Physical Abuse on Anhedonia and Depression
-
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
-
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities
-
Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes
-
Effect of delta-9-tetrahydrocannabinol on behavioral despair and on presynaptic and postsynaptic serotonergic transmission
-
Nature Against Depression
-
Lower levels of cannabinoid 1 receptor mRNA in female eating disorder patients: Association with wrist cutting as impulsive self-injurious behavior
-
Expression pattern of the cannabinoid receptor genes in the frontal cortex of mood disorder patients and mice selectively bred for high and low fear
-
The combined effects of parental divorce and parental history of depression on cannabis use in young adults in France
-
Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes
-
Opposing local effects of endocannabinoids on the activity of noradrenergic neurons and release of noradrenaline: relevance for their role in depression and in the actions of CB(1) receptor antagonists
-
Essential fatty acids and lipid mediators. Endocannabinoids
-
The CB(1) Receptor-Mediated Endocannabinoid Signaling and NGF: The Novel Targets of Curcumin (turmeric)
-
Effect of dietary fat type on anxiety-like and depression-like behavior in mice
-
Cannabinoids, Neurogenesis and Antidepressant Drugs: Is there a Link?
-
Translational evidence for the involvement of the endocannabinoid system in stress-related psychiatric illnesses
-
Endocannabinoid system and mood disorders: Priming a target for new therapies
-
A Randomized Double-blind, Placebo Controlled Trial of Venlafaxine-Extended Release for Co-occurring Cannabis Dependence and Depressive Disorders
-
Low frequency stimulation evokes serotonin release in the nucleus accumbens and induces long-term depression via production of endocannabinoid
-
The effects of anandamide signaling enhanced by the FAAH inhibitor URB597 on coping styles in rats
-
The endocannabinoid system and emotional processing: A pharmacological fMRI study with â9-tetrahydrocannabinol
-
Cannabinoid Receptor Activation Prevents the Effects of Chronic Mild Stress on Emotional Learning and LTP in a Rat Model of Depression
-
Endocannabinoid Signaling in the Etiology and Treatment of Major Depressive Illness
-
The neuroprotective effects of cocoa flavanol and its influence on cognitive performance
-
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
-
Can Marijuana Reduce Social Pain?
-
Screening genetic variability at the CNR1 gene in both major depression etiology and clinical response to citalopram treatment
-
Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain
-
Entopeduncular nucleus endocannabinoid system modulates sleep-waking cycle and mood in rats
-
Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain
-
Sleep Quality Moderates the Relation between Depression Symptoms and Problematic Cannabis Use among Medical Cannabis Users
-
Effects of palmitoylethanolamide and luteolin in an animal model of anxiety/depression
-
The endocannabinoid system and its possible role in neurobiology of psychiatric disorders
-
Testing bidirectional effects between cannabis use and depressive symptoms: moderation by the serotonin transporter gene
-
Antidepressants and Changes in Concentration of Endocannabinoids and NAcylethanolamines in Rat Brain Structures
-
Genetic Variations in the Human Cannabinoid Receptor Gene Are Associated with Happiness
-
Therapeutic benefits of cannabis: a patient survey
-
Effects of chaiyuwendan decoction on endocannabinoids levels in adipose tissue of rats with chronic stress-induced depression
-
Polymorphic expression of CYP2C19 and CYP2D6 in the developing and adult human brain causing variability in cognition, risk for depression and suicide: the search for the endogenous substrates
-
Therapeutic Potential of Inhibitors of Endocannabinoid Degradation for the Treatment of Stress-Related Hyperalgesia in an Animal Model of Chronic Pain
-
Neural Effects of Cannabinoid CB1 Neutral Antagonist Tetrahydrocannabivarin (THCv) on Food Reward and Aversion in Healthy Volunteers
-
Monoacylglycerol Lipase Inhibition Blocks Chronic Stress-Induced Depressive-Like Behaviors via Activation of mTOR Signaling
-
Effects of the fatty acid amide hydrolase inhibitor URB597 on pain-stimulated and pain depressed behavior in rats
-
Cannabinoid Transmission in the Prefrontal Cortex Bi-Phasically Controls Emotional Memory Formation via Functional Interactions with the Ventral Tegmental Area
-
The Endocannabinoid/Endovanilloid System and Depression
-
Relationships between serotonergic and cannabinoid system in depressive-like behavior: a PET study with [11C]-DASB
-
Stress regulates endocannabinoid-CB1 receptor signaling
-
Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease
-
Cannabinoid Type 1 Receptor Availability in the Amygdala Mediates Threat Processing in Trauma Survivors
-
Cannabis use and suicidal ideations in high-school students
-
Nutritional omega-3 modulates neuronal morphology in the prefrontal cortex along with depression-related behaviour through corticosterone secretion
-
Modulation of early stress-induced neurobiological changes: a review of behavioural and pharmacological interventions in animal models
-
Anti-depressive mechanism of repetitive transcranial magnetic stimulation in rat: The role of the endocannabinoid system
-
Is there a role for palmitoylethanolamide in the treatment of depression?
-
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis
-
β-Caryophyllene, a CB2 Receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice
-
Paracetamol potentiates the antidepressant-like and anticompulsive-like effects of fluoxetine
-
The association between cannabis use and mood disorders: A longitudinal study
-
Antidepressant-like and anxiolytic-like effects of cannabidiol: a chemical compound of Cannabis sativa
-
Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity
-
High Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity
-
Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression?
-
Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men
-
Circulating endocannabinoids during hematopoietic stem cell transplantation: A pilot study
-
Mechanisms of stress in the brain
-
Mechanisms of stress in the brain
-
Cannabis use, depression and anxiety: A 3-year prospective population-based study
-
Differential proteomic analysis of the anti-depressive effects of oleamide in a rat chronic mild stress model of depression
-
Involvement of norepinephrine and serotonin system in antidepressant-like effects of oleoylethanolamide in the mice models of behavior despair
-
The potential of inhibitors of endocannabinoid metabolism as anxiolytic and antidepressive drugs-A practical view
-
For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders
-
Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: Mechanism of action and possible interactions with cholinergic system
-
CB1 receptors modulate affective behaviour induced by neuropathic pain
-
Antidepressant-like Effects of Oleoylethanolamide in a Mouse Model of Chronic Unpredictable Mild Stress
-
Smoke Your Troubles Away: Exploring the Effects of Death Cognitions on Cannabis Craving and Consumption
-
The endocannabinoid system role in the pathogenesis of obesity and depression
-
A cannabinoid receptor 1 polymorphism is protective against major depressive disorder in methadone-maintained outpatients
-
Endocannabinoid Modulation of Predator Stress-Induced Long-Term Anxiety in Rats
-
Antidepressant-like activity and cardioprotective effects of fatty acid amide hydrolase inhibitor URB694 in socially stressed Wistar Kyoto rats
-
Endocannabinoids and Mental Disorders
-
Involvement of opioid system in antidepressant-like effect of the cannabinoid CB1 receptor inverse agonist AM-251 after physical stress in mice
-
Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase: New Targets for Future Antidepressants
-
Sex-dependence of anxiety-like behavior in cannabinoid receptor 1 (Cnr1) knockout mice
-
The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent emotional behaviour, and serotonin1A and serotonin2A/C activity in the hippocampus
-
Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors
-
Mediating processes between stress and problematic marijuana use
-
Cannabinoid Receptors May Control Aversive Memories
-
Monoacylglycerol lipase inhibitors produce pro- or antidepressant responses via hippocampal CA1 GABAergic synapses
-
Cyclooxygenase-2 inhibition reduces stress-induced affective pathology
-
Putative Epigenetic Involvement of the Endocannabinoid System in Anxiety- and Depression-Related Behaviors Caused by Nicotine as a Stressor
-
Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects
-
Endocannabinoid-Mediated Plasticity in Nucleus Accumbens Controls Vulnerability to Anxiety after Social Defeat Stress
-
Endocannabinoid signaling in social functioning: an RDoC perspective
-
The relationship between cannabis use and measures of anxiety and depression in a sample of college campus cannabis users and non-users post state legalization in Colorado
-
Marijuana Compounds: A Nonconventional Approach to Parkinsonâs Disease Therapy
-
Endocannabinoid system: Role in depression, reward and pain control (Review)
-
Treating Depression in Alcoholics
-
Ketamine and MAG Lipase Inhibitor-Dependent Reversal of Evolving Depressive Behavior during Forced Abstinence from Alcohol Drinking
-
Role of hypothalamic cannabinoid receptors in post-stroke depression in rats
-
Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex â possible involvement of 5-HT1A and CB1 receptors
-
The endocannabinoid system and NGF are involved in the mechanism of action of resveratrol: a multi-target nutraceutical with therapeutic potential in neuro-psychiatric disorders
-
Potential Biomarkers for Depression Associated with Coronary Artery Disease: A Critical Review
-
Cannabidiol, neuroprotection and neuropsychiatric disorders
-
Placebo effect: clinical, biological and therapeutical involvements in depression
-
Sex and age specific effects of delta-9-tetrahydrocannabinol during the periadolescent period in the rat: The unique susceptibility of the prepubescent animal
-
Sevoflurane Prevents Stroke-induced Depressive and Anxiety Behaviors by Promoting Cannabinoid Receptor Subtype I-dependent Interaction Between β-Arrestin 2 and ERK1/2 in the Rat Hippocampus
-
Gender Differences in Associations Between Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder.
-
Genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma
-
Lipids in psychiatric disorders and preventive medicine
-
Bidirectional Associations Between Cannabis Use and Depressive Symptoms From Adolescence Through Early Adulthood Among At-Risk Young Men
-
Exercise deprivation increases negative mood in exercise-addicted subjects and modifies their biochemical markers
-
Medical marijuana use in head and neck squamous cell carcinoma patients treated with radiotherapy
-
Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?
-
The association of specific traumatic experiences with cannabis initiation and transition to problem use: Differences between African-American and European-American women
-
Dose-dependent cannabis use, depressive symptoms, and FAAH genotype predict sleep quality in emerging adults: a pilot study.
-
Pharmacological inhibition of FAAH activity in rodents: a promising pharmacological approach for psychological â cardiac comorbidity?
-
Association between schizotypal and borderline personality disorder traits, and cannabis use in young adults
-
Prohedonic Effect of Cannabidiol in a Rat Model of Depression
-
Comparing adults who use cannabis medically with those who use recreationally: Results from a national sample
-
New Zealand Health Survey 2012/13: characteristics of medicinal cannabis users
-
Anxiety, depression and risk of cannabis use: Examining the internalising pathway to use among Chilean adolescents
-
The genetic basis of the comorbidity between cannabis use and major depression
-
Anandamide reverses depressive-like behavior, neurochemical abnormalities and oxidative-stress parameters in streptozotocin-diabetic rats: Role of CB1 receptors
-
Contribution of health motive to cannabis use among high-school students
-
Chronic stress leads to epigenetic dysregulation of neuropeptide-Y and cannabinoid CB1 receptor in the mouse cingulate cortex
-
Chronic FAAH inhibition during nicotine abstinence alters habenular CB1 receptor activity and precipitates depressive-like behaviors
-
Targeting the Endocannabinoid System in Psychiatric Illness
-
Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia
-
Sex-dependent influence of chronic mild stress (CMS) on voluntary alcohol consumption, study of neurobiological consequences
-
Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis
-
A dual inhibitor of FAAH and TRPV1 channels shows dose-dependent effect on depression-like behaviour in rats
-
Marijuana Could Help Treat Drug Addiction and Mental Health Problems
DERMATITIS (29)
-
Falcarinol is a covalent cannabinoid CB1 receptor antagonist and induces pro-allergic effects in skin
-
Protective role of palmitoylethanolamide in contact allergic dermatitis
-
Comparative topical anti-inflammatory activity of cannabinoids and cannabivarins
-
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
-
Endocannabinoid signaling and epidermal differentiation
-
Molecular allergology in practice: an unusual case of LTP allergy
-
Differences in peripheral endocannabinoid modulation of scratching behavior in facial vs spinally-innervated skin
-
The role of CB2 receptor ligands in human eosinophil function
-
Inhibitory effect of topical adelmidrol on antigen-induced skin wheal and mast cell behavior in a canine model of allergic dermatitis
-
Endocannabinoids limit excessive mast cell maturation and activation in human skin
-
Cannabinoid receptor type 1 and 2 expression in the skin of healthy dogs and dogs with atopic dermatitis
-
Cannabinoid 1 Receptors in Keratinocytes Modulate Proinflammatory Chemokine Secretion and Attenuate Contact Allergic Inflammation
-
Epigenetic Control of Skin Differentiation Genes by Phytocannabinoids
-
Anti-inflammatory activity of topical THC in DNFB-mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptors
-
The expression of cannabinoid receptor 1 is significantly increased in atopic patients
-
Increased levels of palmitoylethanolamide and other bioactive lipid mediators and enhanced local mast cell proliferation in canine atopic dermatitis
-
TRP channel cannabinoid receptors in skin sensation, homeostasis, and inflammation
-
TRP channel cannabinoid receptors in skin sensation, homeostasis, and inflammation
-
Cannabinoid 1 receptors in keratinocytes attenuate FITC-induced mouse atopic-like dermatitis
-
Harnessing neuroendocrine controls of keratin expression: A new therapeutic strategy for skin diseases?
-
Topical cannabinoid receptor 1 agonist attenuates the cutaneous inflammatory responses in oxazolone-induced atopic dermatitis model
-
Adelmidrol increases the endogenous concentrations of palmitoylethanolamide in canine keratinocytes and down-regulates an inflammatory reaction in an in vitro model of contact allergic dermatitis
-
Selective Cannabinoid Receptor-1 Agonists Regulate Mast Cell Activation in an Oxazolone-Induced Atopic Dermatitis Model
-
N-acyl ethanolamide and eicosanoid involvement in irritant dermatitis
-
Dermatological Aspects of Synthetic Cannabinoid Addiction
-
Anandamide Suppresses Proinflammatory T Cell Responses In Vitro through Type-1 Cannabinoid Receptor-Mediated mTOR Inhibition in Human Keratinocytes
-
Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact allergic dermatitis
-
Targeting Cutaneous Cannabinoid Signaling in Inflammation â A âHighâ-way to Heal?
-
The Endocannabinoid System and Its Role in Eczematous Dermatoses
DIABETES (227)
-
Expression and function of cannabinoid receptors in mouse islets
-
Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain
-
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression
-
Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy
-
Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects
-
Cannabinoid Receptors are Coupled to Stimulation of Insulin Secretion from Mouse MIN6 β-cells
-
Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients
-
Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients
-
Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy
-
A one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetes
-
Rehashing endocannabinoid antagonists: can we selectively target the periphery to safely treat obesity and type 2 diabetes?
-
Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation
-
Polymorphisms in the endocannabinoid receptor 1 in relation to fat mass distribution
-
AMELIORATIVE POTENTIAL OF CANNABIS SATIVA EXTRACT ON DIABETES INDUCED NEUROPATHIC PAIN IN RATS
-
Cannabinoid receptor stimulation impairs mitochondrial biogenesis in mouse white adipose tissue, muscle, and liver: the role of eNOS, p38 MAPK, and AMPK pathways
-
A randomised, double blind, placebo controlled, parallel group, pilot study of 1:1 and 20:1 ratio of formulated GW42003 : GW42004 plus GW42003 and GW42004 alone in the treatment of dyslipidaemia in subjects with Type 2 diabetes
-
American Diabetes Associationâ70th scientific sessionsâresearch on novel therapeutics: part 2
-
Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age
-
Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice
-
AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes
-
Endocannabinoid (EC) Receptor, CB1, and EC Enzymesâ Expression in Primary Adipocyte Cultures of Lean and Obese Pre-pubertal Children in Relation to Adiponectin and Insulin
-
G1359A polymorphism in the cannabinoid receptor-1 gene is associated with metabolic syndrome in the Chinese Han population
-
GPR119 agonists for the potential treatment of type 2 diabetes and related metabolic disorders
-
A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans
-
Protective Role of Cannabinoid Receptor Type 2 in a Mouse Model of Diabetic Nephropathy
-
Cannabinoid receptor 2 signaling does not modulate atherogenesis in mice
-
Hepatic n-3 Polyunsaturated Fatty Acid Depletion Promotes Steatosis and Insulin Resistance in Mice: Genomic Analysis of Cellular Targets
-
Acipimox reduces circulating levels of insulin and associated neutrophilic inflammation in metabolic syndrome
-
Variants at the endocannabinoid receptor CB1 gene (CNR1) and insulin sensitivity, type 2 diabetes, and coronary heart disease
-
Altered endocannabinoid signalling after a high-fat diet in Apoe(-/-) mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance
-
The association of the rs1049353 polymorphism of the CNR1 gene with hypo-adiponectinemia
-
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress
-
GPR119 Regulates Murine Glucose Homeostasis Through Incretin Receptor-Dependent and Independent Mechanisms
-
Central Endocannabinoid Signaling Regulates Hepatic Glucose Production and Systemic Lipolysis
-
Cannabinoids Inhibit Insulin Receptor Signaling in Pancreatic β-Cells
-
TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both post-prandial and fasting hyperglycemia in type 2 diabetic rats
-
Acute cannabinoid receptor type 1 (CB1R) modulation influences insulin sensitivity by an effect outside the central nervous system in mice
-
Expression of the cannabinoid system in muscle: effects of a high fat diet and CB1 receptor blockade
-
Role for cannabinoid receptors in human proximal tubular hypertrophy
-
Cannabinoid receptor agonists and antagonists stimulate insulin secretion from isolated human islets of Langerhans
-
Endocannabinoid signaling and energy metabolism: a target for dietary intervention
-
Cannabinoids and Endocannabinoids in Metabolic Disorders with Focus on Diabetes
-
Win 55,212-2 reduces cardiac ischaemia-reperfusion injury in zucker diabetic fatty rats: role of cb2 receptors and cardiac inos/enos expression
-
Cannabidiol Dampens Streptozotocin-Induced Retinal Inflammation by Targeting of Microglial Activation
-
Functional and Structural Protection by N-Acylethanolamines in Diabetic Retinopathy
-
Decreased prevalence of diabetes in marijuana users: cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) III
-
The cytoprotective effects of oleoylethanolamide in insulin-secreting cells do not require activation of GPR119
-
The L-α-lysophosphatidylinositol/GPR55 system and its potential role in human obesity
-
Endocannabinoids measurement in human saliva as potential biomarker of obesity
-
Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series
-
Type 2 Diabetes Associated Changes in the Plasma Non-Esterified Fatty Acids, Oxylipins and Endocannabinoids
-
Excess of the endocannabinoid anandamide during lactation induces overweight, fat accumulation and insulin resistance in adult mice
-
Relationships between glucose, energy intake and dietary composition in obese adults with type 2 diabetes receiving the cannabinoid 1 (CB1) receptor antagonist, rimonabant
-
Does rimonabant independently affect free fatty acid and glucose metabolism?
-
Metabolic effects of n-3 PUFA as phospholipids are superior to triglycerides in mice fed a high-fat diet: possible role of endocannabinoids
-
Antihyperglycemic and hypolipidemic effects of α, β-amyrin, a triterpenoid mixture from Protium heptaphyllum in mice
-
The Novel Reversible Fatty Acid Amide Hydrolase Inhibitor ST4070 Increases Endocannabinoid Brain Levels and Counteracts Neuropathic Pain in Different Animal Models
-
The Endocannabinoid System: Plant-Derived Cannabinoids in Diabetes and Diabetic Complications
-
Fatty acid amide hydrolase ablation promotes ectopic lipid storage and insulin resistance due to centrally mediated hypothyroidism
-
Stimulating beta cell replication and improving islet graft function by GPR119 agonists
-
Islet protection and amelioration of diabetes type 2 in Psammomys obesus by treatment with cannabidiol
-
Gut microbiota and the development of obesity
-
Characterization of cannabinoid-induced relief of neuropathic pain in rat models of type 1 and type 2 diabetes
-
Ibipinabant attenuates β-cell loss in male Zucker diabetic fatty rats independently of its effects on body weight
-
Overexpression of cannabinoid CB2 receptor in the brain induces hyperglycaemia and a lean phenotype in adult mice
-
Induction of Glucose Intolerance by Acute Administration of Rimonabant
-
TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial
-
A Randomized, Double-Blind, Placebo Controlled, Parallel Assignment, Flexible Dose, Efficacy Study of Nabilone as Adjuvant in the Treatment of Diabetic Peripheral Neuropathic Pain Using an Enriched Enrollment Randomized Withdrawal Design (S38.003)
-
G1359A polymorphism in the cannabinoid receptor-1 gene is associated with the presence of coronary artery disease in patients with type 2 diabetes
-
A Multiple-Ascending-Dose Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Novel GPR40 Agonist, TAK-875, in Subjects With Type 2 Diabetes
-
Optimization of (2,3-dihydro-1-benzofuran-3-yl)acetic acids: discovery of a non-free fatty acid-like, highly bioavailable G protein-coupled receptor 40/free fatty acid receptor 1 agonist as a glucose-dependent insulinotropic agent
-
An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain
-
The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity
-
Reports of the death of CB1 antagonists have been greatly exaggerated: recent preclinical findings predict improved safety in the treatment of obesity
-
Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats
-
New vistas for treatment of obesity and diabetes? Endocannabinoid signalling and metabolism in the modulation of energy balance
-
NEUROPROTECTIVE EFFECTS OF CANNABIS SATIVA ALCOHOLIC EXTRACT AGAINST SPINAL ALPHA MOTONEURONS DEGENERATION IN MALE TYPE II DIABETIC RATS
-
The impact of marijuana use on glucose, insulin, and insulin resistance among US adults
-
Developmental Role for Endocannabinoid Signaling in Regulating Glucose Metabolism and Growth
-
Chronic activation of cannabinoid receptors in vitro does not compromise mouse islet function
-
Influence of G1359A polimorphysm of the cannabinoid receptor gene (CNR1) on insulin resistance and adipokines in patients with non alcoholic fatty liver disease
-
The cannabinoid Î(9)-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity
-
Modulating the endocannabinoid system in human health and disease: successes and failures
-
Reduced Food Intake is the Major Contributor to the Protective Effect of Rimonabant on Islet in Established Obesity-Associated Type 2 Diabetes
-
Circulating endocannabinoids in insulin sensitive vs. Insulin resistant obese post-menopausal women. A MONET group study
-
Insulin induces long-term depression of VTA dopamine neurons via endocannabinoids
-
Is the cardiovascular system a therapeutic target for cannabidiol?
-
The serine hydrolase ABHD6 Is a critical regulator of the metabolic syndrome
-
Cannabinoid Receptor 2 Expression in Human Proximal Tubule Cells is Regulated by Albumin Independent of ERK1/2 Signaling
-
A potential role for GPR55 in gastrointestinal functions
-
A Novel Antidiabetic Drug, Fasiglifam/TAK-875, Acts as an Ago-Allosteric Modulator of FFAR1
-
Randomized, double-blind, dose-ranging study of TAK-875, a novel GPR40 agonist, in Japanese patients with inadequately controlled type 2 diabetes
-
Pharmacometric Approaches to Guide Dose Selection of the Novel GPR40 Agonist TAK-875 in Subjects With Type 2 Diabetes Mellitus
-
Activation of GPR40 as a therapeutic target for the treatment of type 2 diabetes
-
Therapeutic Opportunities through the Modulation of Endocannabinoid Transport
-
TAK-875, a GPR40/FFAR1 agonist, in combination with metformin prevents progression of diabetes and β-cell dysfunction in Zucker diabetic fatty rats
-
Polymorphism rs3123554 in CNR2 reveals gender-specific effects on body weight and affects loss of body weight and cerebral insulin action
-
Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice
-
Common polymorphism in the cannabinoid type 1 receptor gene (CNR1) is associated with microvascular complications in type 2 diabetes
-
Monounsaturated fatty acids generated via stearoyl CoA desaturase-1 are endogenous inhibitors of fatty acid amide hydrolase
-
Medicinal Cannabis and Painful Sensory Neuropathy
-
The complex effects of cannabinoids on insulin secretion from rat isolated islets of Langerhans
-
Effects of CB1 receptor blockade on monosodium glutamate induced hypometabolic and hypothalamic obesity in rats
-
Synergetic Insulin Sensitizing Effect of Rimonabant and BGP-15 in Zucker-Obes Rats
-
Activation of type 2 cannabinoid receptors (CB2R) promotes fatty acid oxidation through the SIRT1/PGC-1α pathway
-
Activation of spinal cannabinoid cb2 receptors inhibits neuropathic pain in streptozotocin-induced diabetic mice
-
Cannabinoids alter endothelial function in the Zucker rat model of type 2 diabetes
-
Biochemical and immunohistochemical changes in delta-9-tetrahydrocannabinol-treated type 2 diabetic rats
-
Long-term supplementation of honokiol and magnolol ameliorates body fat accumulation, insulin resistance, and adipose inflammation in high-fat fed mice
-
Islet cannabinoid receptors: cellular distribution and biological function
-
Role of Genetic Variation in the Cannabinoid Receptor Gene (CNR1) (G1359A Polymorphism) on Weight Loss and Cardiovascular Risk Factors After Liraglutide Treatment in Obese Patients With Diabetes Mellitus Type 2
-
Effects of C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) on weight loss, adipocytokines levels, and insulin resistance after a high polyunsaturated fat diet in obese patients
-
Fasiglifam as a new potential treatment option for patients with type 2 diabetes
-
Docosahexaenoyl ethanolamide improves glucose uptake and alters endocannabinoid system gene expression in proliferating and differentiating C2C12 myoblasts
-
A novel GPR40 agonist, CNX-011-67, suppresses glucagon secretion in pancreatic islets under chronic glucolipotoxic conditions in vitro
-
Effect of intermittent cold exposure on brown fat activation, obesity, and energy homeostasis in mice
-
Vascular targets for cannabinoids: animal and human studies
-
The effects of obesity, diabetes and metabolic syndrome on the hydrolytic enzymes of the endocannabinoid system in animal and human adipocytes
-
Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides
-
A new face of endocannabinoids in pharmacotherapy. Part II. Role of endocannabinoids in inflammation-derived cardiovascular diseases
-
Molecular matchmaking between the popular weight-loss herb Hoodia gordonii and GPR119, a potential drug target for metabolic disorder
-
The G-Protein-Coupled Long-Chain Fatty Acid Receptor GPR40 and Glucose Metabolism
-
Selected terpenoids from medicinal plants modulate endoplasmic reticulum stress in metabolic disorders
-
Glucose concentration in culture medium affects mRNA expression of TRPV1 and CB1 receptors and changes capsaicin toxicity in PC12 cells
-
Optimization of GPR40 Agonists for Type 2 Diabetes
-
Mitochondria: A Possible Nexus for the Regulation of Energy Homeostasis by the Endocannabinoid System?
-
Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy
-
Acute Activation of Cannabinoid Receptors by Anandamide Reduces Gastro-Intestinal Motility and Improves Postprandial Glycemia in Mice
-
Cannabidiol improves vasorelaxation in Zucker Diabetic fatty rats through cyclo-oxygenase activation
-
Cannabis use in relation to obesity and insulin resistance in the inuit population
-
A Role for Trans-caryophyllene in the Moderation of Insulin Secretion
-
Glucose metabolism: Focus on gut microbiota, the endocannabinoid system and beyond
-
Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice
-
GPR55: From orphan to metabolic regulator?
-
Physiology and therapeutics of the free fatty acid receptor GPR40
-
G-protein coupled receptor 40 agonists as novel therapeutics for type 2 diabetes
-
Selected CNR1 polymorphisms and hyperandrogenemia as well as fat mass and fat distribution in women with polycystic ovary syndrome
-
Oxidative stress and cannabinoid receptor expression in type-2 diabetic rat pancreas following treatment with Î9-THC
-
Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment
-
Potential applications of marijuana and cannabinoids in medicine
-
Elevated CB1 and GPR55 receptor expression in proximal tubule cells and whole kidney exposed to diabetic conditions
-
Role of orphan G protein-coupled receptor 55 in diabetic gastroparesis in mice
-
The antidiabetic and hepatoprotective effects of magnolol on diabetic rats induced by high-fat diet and streptozotocin
-
Gastrointestinal hormonal responses on GPR119 activation in lean and diseased rodent models of type 2 diabetes
-
α/β-Hydrolase Domain-6-Accessible Monoacylglycerol Controls Glucose-Stimulated Insulin Secretion
-
Increased Plasma Levels of FABP4 and PTEN Is Associated with More Severe Insulin Resistance in Women with Gestational Diabetes Mellitus
-
Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases
-
Changes in Plasma Levels of N-Arachidonoyl Ethanolamine and NPalmitoylethanolamine following Bariatric Surgery in Morbidly Obese Females with Impaired Glucose Homeostasis
-
Fat Diet-Induced Insulin Resistance Does Not Increase Plasma Anandamide Levels or Potentiate Anandamide Insulinotropic Effect in Isolated Canine Islets
-
Atypical diabetic ketoacidosis: case report
-
Role of the endocannabinoid system in obesity induced by neuropeptide Y over-expression in noradrenergic neurons
-
Diacylglycerol lipase α knockout mice demonstrate metabolic and behavioral phenotypes similar to those of cannabinoid receptor 1 knockout mice
-
Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation
-
N-Oleoyl glycine, a lipoamino acid, stimulates adipogenesis associated with activation of CB1 receptor and Akt signaling pathway in 3T3-L1 adipocyte
-
Cannabis â the Israeli perspective
-
Circulating Endocannabinoids and the Polymorphism 385C>A in Fatty Acid Amide Hydrolase (FAAH) Gene May Identify the Obesity Phenotype Related to Cardiometabolic Risk: A Study Conducted in a Brazilian Population of Complex Interethnic Admixture
-
Cannabinoid CB1 receptors and mTORC1 signalling pathway interact to modulate glucose homeostasis
-
Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH)
-
Dietary DHA reduced downstream endocannabinoid and inflammatory gene expression, epididymal fat mass, and improved aspects of glucose use in muscle in C57BL/6J mice
-
Renal effects of chronic pharmacological manipulation of CB2 receptors in rats with dietinduced obesity
-
Alterations in the Medullary Endocannabinoid System Contribute to Age-related Impairment of Baroreflex Sensitivity
-
Cannabis Smoking and Diabetes Mellitus: Results from Meta-analysis with Eight Independent Replication Samples
-
Role of the Endocannabinoid System in Diabetes and Diabetic Complications
-
Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy
-
Endocannabinoid system activation may be associated with insulin resistance in women with polycystic ovary syndrome
-
CB1R antagonist increases hepatic insulin clearance in fat-fed dogs likely via upregulation of liver adiponectin receptors
-
Intake of farmed Atlantic salmon fed soybean oil increases hepatic levels of arachidonic acid-derived oxylipins and ceramides in mice
-
Marijuana use and risk of prediabetes and diabetes by middle adulthood: the Coronary Artery Risk Development in Young Adults (CARDIA) study
-
The emerging role of the endocannabinoid system in the pathogenesis and treatment of kidney diseases
-
GPR40 agonists for the treatment of type 2 diabetes: life after âTAKingâ a hit
-
Direct activation of the proposed anti-diabetic receptor, GPR119 in cardiomyoblasts decreases markers of muscle metabolic activity
-
Influence of nitric oxide synthase or cyclooxygenase inhibitors on cannabinoids activity in streptozotocin-induced neuropathy
-
Angiotensin II receptor blockers decrease serum concentration of fatty acid-binding protein 4 in patients with hypertension
-
Major urinary protein 1 interacts with cannabinoid receptor type 1 in fatty acid-induced hepatic insulin resistance in a mouse hepatocyte model
-
Cannabinoid functions in the amygdala contribute to conditioned fear memory in streptozotocin-induced diabetic mice: interaction with glutamatergic functions
-
Death due to diabetic ketoacidosis: Induction by the consumption of synthetic cannabinoids?
-
New insights on the role of the endocannabinoid system in the regulation of energy balance
-
Endocannabinoids and Metabolic Disorders
-
Endocannabinoids and the Cardiovascular System in Health and Disease
-
Deletion of G-protein coupled receptor 55 promotes obesity by reducing physical activity
-
Therapy with a Selective Cannabinoid Receptor Type 2 Agonist Limits Albuminuria and Renal Injury in Mice with Type 2 Diabetic Nephropathy
-
Endocannabinoids â at the crossroads between the gut microbiota and host metabolism
-
Blockade of Cannabinoid 1 Receptor Improves GLP-1R Mediated Insulin Secretion in Mice
-
G protein-coupled receptors: signalling and regulation by lipid agonists for improved glucose homoeostasis
-
GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus: Benefits and Challenges
-
Lipid signaling in adipose tissue: Connecting inflammation & metabolism
-
Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease
-
Circulating Endocannabinoids and Insulin Resistance in Patients with Obstructive Sleep Apnea
-
Cannabinoids Regulate Bcl-2 and Cyclin D2 Expression in Pancreatic β Cells
-
New insights into the yin and yang of the endocannabinoid system in health and disease
-
Mechanisms underlying glucoseâdependent insulinotropic polypeptide and glucagonâlike peptideâ1 secretion
-
Impaired Excitatory Neurotransmission in the Urinary Bladder from the Obese Zucker Rat: Role of Cannabinoid Receptors
-
Metabolic Syndrome Among Marijuana Users in the United States: An Analysis of National Health and Nutrition Examination Survey Data
-
Controlled downregulation of the cannabinoid CB1 receptor provides a promising approach for the treatment of obesity and obesity-derived type 2 diabetes
-
CB1 receptor blockade counters age-induced insulin resistance and metabolic dysfunction
-
Prolonged activation of human islet cannabinoid receptors in vitro induces adaptation but not dysfunction
-
The effect of spinally administered WIN 55,212-2, a cannabinoid agonist, on thermal pain sensitivity in diabetic rats
-
Endocannabinoids in Feeding Behavior and Energy Homeostasis
-
Mice Expressing a âHyper-Sensitiveâ Form of the Cannabinoid Receptor 1 (CB1) Are Neither Obese Nor Diabetic
-
Human CB1 Receptor Isoforms, present in Hepatocytes and β-cells, are Involved in Regulating Metabolism
-
Cannabis Use as Risk or Protection for Type 2 Diabetes: A Longitudinal Study of 18â000 Swedish Men and Women
-
Role of cannabinoid receptor 1 in human adipose tissue for lipolysis regulation and insulin resistance
-
Cannabinoid 2 Receptor Agonist Improves Systemic Sensitivity to Insulin in High-Fat Diet/Streptozotocin-Induced Diabetic Mice
-
α/β-Hydrolase Domain 6 in the Ventromedial Hypothalamus Controls Energy Metabolism Flexibility
-
Endocannabinoid regulation of β-cell functions: Implications for glycemic control and diabetes
-
Early Low Fat Diet Enriched with Linolenic Acid Reduces Liver Endocannabinoid Tone and Improves Late Glycemic Control After a High Fat Diet Challenge in Mice
-
Effects of activation of endocannabinoid system on myocardial metabolism. (click âICIâ for
-
G protein-coupled receptor 18: A potential role for endocannabinoid signalling in metabolic dysfunction
-
Impaired cued and spatial learning performance and altered cannabinoid CB1 receptor functionality in the substantia nigra in a rat model of diabetic neuropathy
-
β-Caryophyllene, a natural sesquiterpene lactone attenuates hyperglycemia mediated oxidative and inflammatory stress in experimental diabetic rats
-
Cannabinoid receptor type 1 mediates high-fat diet-induced insulin resistance by increasing forkhead box O1 activity in a mouse model of obesity
-
Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine neuropathic pain model
-
G protein-coupled receptor 18: A potential role for endocannabinoid signalling in metabolic dysfunction
-
Cannabinoids and autoimmune diseases: A systematic review
-
Role of cannabinoid receptors in renal diseases
-
Endovanilloid control of pain modulation by the rostroventromedial medulla in an animal model of diabetic neuropathy
-
The role of carbon monoxide on the anti-nociceptive effects and expression of cannabinoid 2 receptors during painful diabetic neuropathy in mice
-
Hierarchical glucocorticoid-endocannabinoid interplay regulates the activation of the nucleus accumbens by insulin
-
Fasiglifam/TAK-875, a Selective GPR40 Agonist, Improves Hyperglycemia in Rats Unresponsive to Sulfonylureas and Acts Additively with Sulfonylureas
-
Long-term safety and efficacy of fasiglifam (TAK-875), a G-protein-coupled receptor 40 agonist, as monotherapy and combination therapy in Japanese patients with type 2 diabetes: a 52-week open-label phase III study
-
Anandamide reverses depressive-like behavior, neurochemical abnormalities and oxidative-stress parameters in streptozotocin-diabetic rats: Role of CB1 receptors
-
GPR55-dependent stimulation of insulin secretion from isolated mouse and human islets of Langerhans
-
Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo Controlled, Parallel Group Pilot Study
-
Marijuana Use and Type 2 Diabetes Mellitus: a Review
-
Experimental cannabidiol treatment reduces early pancreatic inflammation in type 1 diabetes
-
Cannabinoid receptors and TRPA1 on neuroprotection in a model of retinal ischemia
-
Developmental Role of Macrophage Cannabinoid-1 Receptor Signaling in Type-2 Diabetes
DIARRHEA (22)
-
Small intestinal cannabinoid receptor changes following a single colonic insult with oil of mustard in mice
-
Pharmacogenetic Trial of a Cannabinoid Agonist Shows Reduced Fasting Colonic Motility in Patients with Non-Constipated Irritable Bowel Syndrome
-
US Patent 7884133 B2 Cannabidiol derivatives such as 3-(2,6-dihydroxy-4- pentylphenyl)-4-prop-1-en-2-ylcyclohexene-1-carboxylic acid, used as as analgesics, antiinflammatory and antidiarrheal agents
-
Cannabis use amongst patients with inflammatory bowel disease
-
Medical cannabis: the opportunity versus the temptation
-
Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea
-
Efficacy of a dose range of surinabant, a cannabinoid receptor blocker, for smoking cessation: a randomized controlled clinical trial
-
Pro-resolution, protective and anti-nociceptive effects of a cannabis extract in the rat gastrointestinal tract
-
Cannabinoid Receptor 1 Gene and Irritable Bowel Syndrome: Phenotype and Quantitative Traits
-
Effect of high fat-diet and obesity on gastrointestinal motility
-
Endocannabinoid and cannabinoid-like fatty acid amide levels correlate with pain-related symptoms in patients with IBS-D and IBS-C: a pilot study
-
Role of endogenous cannabinoid system in the gut
-
Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides
-
Cannabis for inflammatory bowel disease
-
Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohnâs disease
-
The long-term functional consequences of acute infectious diarrhea
-
The role of cannabinoids in regulation of nausea and vomiting, and visceral pain
-
May cannabinoids prevent the development of chemotherapy-induced diarrhea and intestinal mucositis? Experimental study in the rat
-
Role of cannabinoids in gastrointestinal mucosal defense and inflammation
-
Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review
-
Role of cannabis in digestive disorders
-
Role of cannabis in digestive disorders
DRIVING AND CANNABIS (63)
-
Sex Differences in the Effects of Marijuana on Simulated Driving Performance
-
The effects of cannabis and alcohol on simulated arterial driving: Influences of driving experience and task demand
-
Medical Marijuana Laws, Traffic Fatalities, and Alcohol Consumption
-
The prevalence of cannabis-involved driving in California
-
Alcohol, psychoactive drugs and fatal road traffic accidents in Norway: a case-control study
-
Psychomotor Performance, Subjective and Physiological Effects and Whole Blood Î9-Tetrahydrocannabinol Concentrations in Heavy, Chronic Cannabis Smokers Following Acute Smoked Cannabis
-
A placebo-controlled study to assess Standardized Field Sobriety Tests performance during alcohol and cannabis intoxication in heavy cannabis users and accuracy of point of collection testing devices for detecting THC in oral fluid
-
The Therapeutic Potential of Cannabis and Cannabinoids
-
Cannabis and psychomotor performance: A rational review of the evidence and implications for public policy
-
Cannabis use: a perspective in relation to the proposed UK drug-driving legislation
-
Impact of prolonged cannabinoid excretion in chronic daily cannabis smokersâ blood on per se drugged driving laws
-
Prevalence of alcohol and other drugs and the concentrations in blood of drivers killed in road traffic crashes in Sweden
-
THCCOOH concentrations in whole blood: Are they useful in discriminating occasional from heavy smokers?
-
Comparison between self-report of cannabis use and toxicological detection of THC / THCCOOH in blood and THC in oral fluid in drivers in a roadside survey
-
Driving Under the Influence of Cannabis: Pitfalls, Validation, and Quality Control of a UPLC-MS/MS Method for the Quantification of Tetrahydrocannabinol in Oral Fluid Collected With StatSure, Quantisal, or Certus Collector
-
Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain
-
Risk of severe driver injury by driving with psychoactive substances
-
Police custody following driving under the influence of cannabis: A prospective study
-
Blood Synthetic Cannabinoid Concentrations in Cases of Suspected Impaired Driving
-
Prevalence of synthetic cannabinoids in blood samples from Norwegian drivers suspected of impaired driving during a seven weeks period
-
Analysis of AM-2201 and metabolites in a drugs and driving case
-
Analysis of AM-2201 and metabolites in a drugs and driving case
-
Marijuana Policy in Colorado
-
Adverse psychosocial outcomes associated with drug use among US high school seniors: a comparison of alcohol and marijuana
-
Blood levels do not predict behavioral or physiological effects of Îâ¹-tetrahydrocannabinol in rhesus monkeys with different patterns of exposure
-
XLR-11 and UR-144 in Washington State and State of Alaska Driving Cases
-
Cannabis Use and its Effects on Health, Education and Labor Market Success
-
An examination of the validity of the standardized field sobriety test in detecting drug impairment using data from the drug evaluation and classification program
-
Driving under the influence of synthetic cannabinoids (âSpiceâ): a case series
-
The culpability of drivers killed in New Zealand road crashes and their use of alcohol and other drugs
-
Determination of Î9-tetrahydrocannabinolic acid A (Î9-THCA-A) in whole blood and plasma by LC-MS/MS and application in authentic samples from drivers suspected of driving under the influence of cannabis
-
Cannabinoids determination in oral fluid by SPME-GC/MS and UHPLC-MS/MS and its application on suspected drivers
-
Status Report: Marijuana Legalization in Colorado After One Year of Retail Sales and Two Years of Decriminalization
-
Drug and Alcohol Crash Risk
-
Controlled Cannabis Vaporizer Administration: Blood and Plasma Cannabinoids with and without Alcohol
-
Comparing treatment effects of oral THC on simulated and on-the-road driving performance: testing the validity of driving simulator drug research
-
Medical marijuanaâs public health lessonsâimplications for retail marijuana in Colorado
-
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drugâs harm to children and adults, but the scientific evidence is seldom clear-cut
-
Peaceful feeling, or up in smoke? Medical marijuana in medicolegal context
-
Drug-resistant MS spasticity treatment with Sativex® add-on and driving ability
-
The Influence of Synthetic Cannabinoid UR-144 on Human Psychomotor Performance -A Case Report Demonstrating Road Traffic Risks
-
Delays in DUI blood testing: Impact on cannabis DUI assessments
-
Driving Under the Influence of Marijuana Versus Driving and Dying Under the Influence of Marijuana: A Comparison of Blood Concentrations of Î9-Tetrahydrocannabinol, 11-Hydroxy-Î9-Tetrahydrocannabinol, 11-Nor-9-Carboxy-Î9-Tetrahydrocannabinol and Other Cannabinoids in Arrested Drivers Versus Deceased Drivers
-
Concentrations of AB-CHMINACA and AB-PINACA and Driving Behavior in Suspected Impaired Driving Cases
-
Tetrahydrocannabinol pharmacokinetics, new synthetic cannabinoids, road safety and cannabis
-
Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs
-
Ion mobility spectrometry for detection of Cannabis sativa L. metabolites from exhaled breath
-
The impact of marijuana decriminalization on California drivers
-
Restraint use and risky driving behaviors across drug types and drug and alcohol combinations for drivers involved in a fatal motor vehicle collision on U.S. roadways
-
Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues
-
Dose of Reality: The Effect of State Marijuana Legalizations
-
The effect of cannabis on regular cannabis consumersâ ability to ride a bicycle
-
Effect of Blood Collection Time on Measured Î9-Tetrahydrocannabinol Concentrations: Implications for Driving Interpretation and Drug Policy
-
The Changing Drug Culture: Medical and Recreational Marijuana
-
Cannabis effects on driving longitudinal control with and without alcohol
-
The effects of cannabis intoxication on motor vehicle collision revisited and revised
-
Traffic accidentability and risky driving behavior in young people in New Caledonia. Results of study
-
A multicenter retrospective survey of poisoning after consumption of products containing novel psychoactive substances from 2013 to 2014 in Japan
-
State Medical Marijuana Laws and the Prevalence of Opioids Detected Among Fatally Injured Drivers
-
Persistent cannabis dependence and alcohol dependence represent risks for midlife economic and social problems: A longitudinal cohort study
-
US Traffic Fatalities, 1985â2014, and Their Relationship to Medical Marijuana Laws
-
Self-reported Driving Under the Influence of Alcohol and Cannabis Among Ontario Students: Associations with Graduated Licensing, Risk Taking and Substance Abuse
-
Evaluation of divided attention psychophysical task performance and effects on pupil sizes following smoked, vaporized and oral cannabis administration
DRUG TESTING (58)
-
Testing for cannabis in the work-place: a review of the evidence
-
Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in âherbal highâ products
-
Zinc Reduces the Detection of Cocaine, Methamphetamine, and THC by ELISA Urine Testing
-
Cannabinoids in postmortem toxicology
-
Postmortem redistribution of Î9-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OHTHC), and 11-nor-9-carboxy-THC (THCCOOH)
-
Prolonged excretion half-life of 11-nor-9-carboxy-Îâ¹-THC following cessation in a chronic, heavy marijuana user: implications for liver transplant assessment
-
Immunochemical approach using monoclonal antibody against Î(9)-tetrahydrocannabinolic acid (THCA) to discern cannabis plants and to investigate new drug candidates
-
A preliminary investigation on the distribution of cannabinoids in man
-
Prolonged excretion half-life of 11-nor-9-carboxy-Îâ¹-THC following cessation in a chronic, heavy marijuana user: implications for liver transplant assessment
-
Simultaneous determination of delta-9-tetrahydrocannabinol cannabidiol and cannabinol in edible oil using ultra performance liquid chromatography-tandem mass spectrometry
-
Metabolic acidosis, hypoglycemia, and severe myalgias: an attempt to mask urine drug screen results
-
A placebo-controlled study to assess Standardized Field Sobriety Tests performance during alcohol and cannabis intoxication in heavy cannabis users and accuracy of point of collection testing devices for detecting THC in oral fluid
-
Cannabis misinterpretation and misadventure in a coronerâs court
-
Cannabis misinterpretation and misadventure in a coronerâs court
-
Cannabis â from cultivar to chemovar
-
Unexpected interference of baby wash products with a cannabinoid (THC) immunoassay
-
Detecting impairment associated with cannabis with and without alcohol on the Standardized Field Sobriety Tests
-
Are cannabis prevalence estimates comparable across countries and regions? A cross-cultural validation using search engine query data
-
Does a positive finding of tetrahydrocannabinol in the blood result from ingestion of Indian frankincense (Boswellia serrata)?
-
Manual for use by national drug analysis laboratories Recommended methods for the Identification and Analysis of Synthetic Cannabinoid Receptor Agonists in Seized Materials
-
Oral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration
-
Identification and Structural Elucidation of Four Cannabimimetic Compounds (RCS-4, AM-2201, JWH-203 and JWH-210in Seized Products
-
Elevated urine zinc concentration reduces the detection of methamphetamine, cocaine, THC and opiates in urine by EMIT
-
Identification of Novel Third-Generation Synthetic Cannabinoids in Products by UltraPerformance Liquid Chromatography and Time-of-Flight Mass Spectrometry
-
Marijuana Poisoning (dogs)
-
Analysis of THCA synthase gene expression in cannabis: A preliminary study by realtime quantitative PCR
-
An in vitro experiment on the interaction of charcoal or wheat bran with 11-nor-9-carboxy-Î9-tetrahydrocannabinol and its glucuronide
-
Tricks and Tracks in the Identification and Quantification of Endocannabinoids
-
Synthetic cannabinoid use among patients in residential substance use disorder treatment: Prevalence, motives, and correlates
-
An examination of the validity of the standardized field sobriety test in detecting drug impairment using data from the drug evaluation and classification program
-
Metals and organic compounds in the biosynthesis of cannabinoids: a chemometric approach to the analysis of Cannabis sativa samples
-
Workplace drug testing in Italy: Findings about second-stage testing
-
Behaviours of psychotropic substances in indoor and outdoor environments of Rome, Italy
-
Cocaineâs fall and marijuanaâs rise: questions and insights based on new estimates of consumption and expenditures in US drug markets
-
A structure-reactivity relationship driven approach to the identification of a color test protocol for the presumptive indication of synthetic cannabimimetic drugs of abuse
-
Population Pharmacokinetic Model of THC Integrates Oral, Intravenous, and Pulmonary Dosing and Characterizes Short- and Long-term Pharmacokinetics
-
Simultaneous quantification of delta-9-THC, THC-acid A, CBN and CBD in seized drugs using HPLC-DAD
-
Non-smoker exposure to secondhand cannabis smoke. I. Urine screening and confirmation results
-
Non-smoker exposure to secondhand cannabis smoke II: Effect of room ventilation on the physiological, subjective, and behavioral/cognitive effects
-
Annual banned-substance review: analytical approaches in human sports drug testing
-
A Reliable Method for the Separation and Detection of Synthetic Cannabinoids by Supercritical Fluid Chromatography with Mass Spectrometry, and Its Application to Plant Products
-
Emerging drugs of abuse: current perspectives on synthetic cannabinoids
-
Seized cannabis seeds cultivated in greenhouse: A chemical study by gas chromatographyâmass spectrometry and chemometric analysis
-
Method for the Analysis of Cannabinoids and Terpenes in Cannabis
-
A robust capillary liquid chromatography/tandem mass spectrometry method for quantitation of neuromodulatory endocannabinoids
-
Determination of 11 Cannabinoids in Biomass and Extracts of Different Varieties of Cannabis Using High-Performance Liquid Chromatography
-
Population Pharmacokinetic Model of THC Integrates Oral, Intravenous, and Pulmonary Dosing and Characterizes Short- and Long-term Pharmacokinetics
-
Lipidomic Analysis of Endocannabinoid Signaling: Targeted Metabolite Identification and Quantification
-
Simultaneous detection of 93 synthetic cannabinoids by liquid chromatography-tandem mass spectrometry and retrospective application to real forensic samples
-
Techniques and technologies for the bioanalysis of Sativex®, metabolites and related compounds
-
Medicinal cannabis: Principal cannabinoids concentration and their stability evaluated by a high performance liquid chromatography coupled to diode array and quadrupole time of flight mass spectrometry method
-
Extraction and Simultaneous Quantification of Endocannabinoids and Endocannabinoid Like Lipids in Biological Tissues
-
The Application of Voltammetric Analysis of Î(9) -THC for the Reduction of False Positive Results in the Analysis of Suspected Marijuana Plant Matter
-
Synthetic cannabinoids to avoid urine drug screens: Implications for contingency management and other treatments for drug dependence
-
Use of Embryos Extracted from Individual Cannabis sativa Seeds for Genetic Studies and Forensic Applications
-
Buying drugs on a Darknet market: A better deal? Studying the online illicit drug market through the analysis of digital, physical and chemical data
-
Interpretation of Workplace Tests for Cannabinoids
-
A systematic review of passive exposure to cannabis
DRUG TESTING-BLOOD/PLASMA (83)
-
Concentrations of delta9-tetrahydrocannabinol and 11-nor-9-carboxytetrahydro-cannabinol in blood and urine after passive exposure to Cannabis smoke in a coffee shop
-
Quantitation of Total 11-Nor-9-Carboxy-Delta 9-Tetrahydrocannabinol in Urine and Blood Using Gas Chromatography-Mass Spectrometry (GC-MS)
-
Interpretation of blood analysis data found after passive exposure to cannabis
-
Testing for cannabis in the work-place: a review of the evidence
-
Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration
-
Oral Fluid and Plasma Cannabinoid Ratios after Around-the-Clock Controlled Oral [Delta]9-Tetrahydrocannabinol Administration
-
Identification of Recent Cannabis Use:Whole-Blood and Plasma Free and Glucuronidated Cannabinoid Pharmacokinetics Following Controlled Smoked Cannabis Administration
-
Influence of ethanol on cannabinoid pharmacokinetic parameters in chronic users
-
Variability of cannabinoid findings in blood
-
Psychomotor Performance, Subjective and Physiological Effects and Whole Blood Î9-Tetrahydrocannabinol Concentrations in Heavy, Chronic Cannabis Smokers Following Acute Smoked Cannabis
-
Detection and disposition of JWH-018 and JWH-073 in mice after exposure to âMagic Goldâ smoke
-
Determination of naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in mouse blood and tissue after inhalation exposure to âbuzzâ smoke by HPLC/MS/MS
-
Detection and quantification of new designer drugs in human blood: part 1 â synthetic cannabinoids
-
Predictive model accuracy in estimating last Î(9)-tetrahydrocannabinol (THC) intake from plasma and whole blood cannabinoid concentrations in chronic, daily cannabis smokers administered subchronic oral THC
-
Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction
-
Does a positive finding of tetrahydrocannabinol in the blood result from ingestion of Indian frankincense (Boswellia serrata)?
-
Determination of the two major endocannabinoids in human plasma by μ-SPE followed by HPLC-MS/MS
-
Distribution of free and conjugated cannabinoids in human bile samples
-
Dried Blood Spots: Liquid chromatography-mass spectrometry analysis of Î(9)-tetrahydrocannabinol and its main metabolites
-
In Vitro Stability of Free and Glucuronidated Cannabinoids in Blood and Plasma Following Controlled Smoked Cannabis
-
Impact of prolonged cannabinoid excretion in chronic daily cannabis smokersâ blood on per se drugged driving laws
-
Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the world trade center attacks
-
Oral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration
-
Plasma Cannabinoid Concentrations During Dronabinol Pharmacotherapy for Cannabis Dependence
-
Endocannabinoid and cannabinoid-like fatty acid amide levels correlate with pain-related symptoms in patients with IBS-D and IBS-C: a pilot study
-
Prevalence of synthetic cannabinoids in blood samples from Norwegian drivers suspected of impaired driving during a seven weeks period
-
THCCOOH concentrations in whole blood: Are they useful in discriminating occasional from heavy smokers?
-
Simultaneous and sensitive LCâMS/MS determination of tetrahydrocannabinol and metabolites in human plasma
-
Exercise increases plasma THC concentrations in regular cannabis users
-
Prevalence of synthetic cannabinoids in blood samples from Norwegian drivers suspected of impaired driving during a seven weeks period
-
Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint
-
Prevalence of alcohol and other drugs and the concentrations in blood of drivers killed in road traffic crashes in Sweden
-
Quantification of anandamide and 2-arachidonoylglycerol plasma levels to examine potential influences of tetrahydrocannabinol application on the endocannabinoid system in humans
-
Can Physical Exercise or Food Deprivation Cause Release of Fat-Stored Cannabinoids
-
Performance, egg quality, and blood plasma chemistry of laying hens fed hempseed and hempseed oil
-
Blood levels do not predict behavioral or physiological effects of Îâ¹-tetrahydrocannabinol in rhesus monkeys with different patterns of exposure
-
Phase I and II Cannabinoid Disposition in Blood and Plasma of Occasional and Frequent Smokers Following Controlled Smoked Cannabis
-
Fasting and exercise increase plasma cannabinoid levels in THC pre-treated rats: an examination of behavioural consequences
-
A One-Step Extraction Procedure for the Screening of Cocaine, Amphetamines and Cannabinoids in Postmortem Blood Samples
-
Determination of Î9-tetrahydrocannabinolic acid A (Î9-THCA-A) in whole blood and plasma by LC-MS/MS and application in authentic samples from drivers suspected of driving under the influence of cannabis
-
Spot them in the spot: analysis of abused substances using dried blood spots
-
Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification: cannabis withdrawal syndrome and its correlation with delta-9-tetrahydrocannabinol and -metabolites in serum
-
A quantitiative LC-MS/MS method for the measurement of arachidonic acid, prostanoids, endocannabinoids, N-acylethanolamines and steroids in human plasma
-
Controlled Cannabis Vaporizer Administration: Blood and Plasma Cannabinoids with and without Alcohol
-
Nonsmoker Exposure to Secondhand Cannabis Smoke. III. Oral Fluid and Blood Drug Concentrations and Corresponding Subjective Effects
-
Plasma Cannabinoid Pharmacokinetics After Controlled Smoking and Ad libitum Cannabis Smoking in Chronic Frequent Users
-
High-throughput salting-out assisted liquid-liquid extraction with acetonitrile for the determination of anandamide in plasma of hemodialysis patients with liquid chromatography tandem mass spectrometry
-
Residual cannabis levels in blood, urine and oral fluid following heavy cannabis use
-
Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices
-
Simultaneous determination of endocannabinoids in murine plasma and brain substructures by surrogate-based LC-MS/MS: Application in tumor-bearing mice
-
Development of a simple and sensitive HPLC-UV method for the simultaneous determination of cannabidiol and Î9-tetrahydrocannabinol in rat plasma
-
Delays in DUI blood testing: Impact on cannabis DUI assessments
-
Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance
-
Controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationships
-
In vivo detection of the new psychoactive substance AM-694 and its metabolites
-
Death due to diabetic ketoacidosis: Induction by the consumption of synthetic cannabinoids?
-
Driving Under the Influence of Marijuana Versus Driving and Dying Under the Influence of Marijuana: A Comparison of Blood Concentrations of Î9-Tetrahydrocannabinol, 11-Hydroxy-Î9-Tetrahydrocannabinol, 11-Nor-9-Carboxy-Î9-Tetrahydrocannabinol and Other Cannabinoids in Arrested Drivers Versus Deceased Drivers
-
Concentrations of AB-CHMINACA and AB-PINACA and Driving Behavior in Suspected Impaired Driving Cases
-
Tetrahydrocannabinol pharmacokinetics, new synthetic cannabinoids, road safety and cannabis
-
Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis
-
In vitro stability of free and glucuronidated cannabinoids in blood and plasma collected in plastic gray-top sodium fluoride tubes following controlled smoked cannabis
-
Development of a rapid column-switching LC-MS/MS method for the quantification of THCCOOH and THCCOOH-glucuronide in whole blood for assessing cannabis consumption frequency
-
A preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabis
-
Comparison of Cannabinoid Concentrations in Plasma, Oral Fluid and Urine in Occasional Cannabis Smokers After Smoking Cannabis Cigarette (link to
-
Simultaneous detection of 93 synthetic cannabinoids by liquid chromatography-tandem mass spectrometry and retrospective application to real forensic samples
-
Development of a rapid column-switching LC-MS/MS method for the quantification of THCCOOH and THCCOOH-glucuronide in whole blood for assessing cannabis consumption frequency
-
Effect of Blood Collection Time on Measured Î9-Tetrahydrocannabinol Concentrations: Implications for Driving Interpretation and Drug Policy
-
Techniques and technologies for the bioanalysis of Sativex®, metabolites and related compounds
-
The therapeutic use of cannabinoids: Forensic aspects
-
Drug Recognition Expert (DRE) examination characteristics of cannabis impairment
-
Optimized extraction of 2-arachidonyl glycerol and anandamide from aortic tissue and plasma for quantification by LC-MS/MS
-
Analysis of Omega-3 Fatty Acid Derived N-Acylethanolamines in Biological Matrices
-
Identification of the oleic acid ethanolamide (OEA) isomer cis-vaccenic acid ethanolamide (VEA) as a highly abundant 18:1 fatty acid ethanolamide in blood plasma from rats and humans
-
Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [11C]CURB
-
Cannabis Hyperemesis Syndrome in the Emergency Department: How Can a Specialized Addiction Team Be Useful? A Pilot Study
-
A novel microflow LC-MS method for the quantitation of endocannabinoids in serum
-
Assessing cannabis consumption frequency: Is the combined use of free and glucuronidated THCCOOH blood levels of diagnostic utility?
-
Freeze-and-thaw stability and long-term-stability of 84 synthetic cannabinoids in serum
-
A systematic review of passive exposure to cannabis.
-
Free and Glucuronide Whole Blood Cannabinoidsâ Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake
-
Dried haematic microsamples and LC-MS/MS for the analysis of natural and synthetic cannabinoids
-
ical application of THC containing products is not able to cause positive cannabinoid finding in blood or urine
-
Evaluation of divided attention psychophysical task performance and effects on pupil sizes following smoked, vaporized and oral cannabis administration
DRUG TESTING-BREATH TEST (7)
-
Detection of δ(9)-tetrahydrocannabinol in exhaled breath collected from cannabis users
-
Detection of drugs of abuse in exhaled breath from users following recovery from intoxication
-
Cannabinoids in Exhaled Breath following Controlled Administration of Smoked Cannabis
-
Application of drug testing using exhaled breath for compliance monitoring of drug addicts in treatment
-
Method validation and application of a liquid chromatography-tandem mass spectrometry method for drugs of abuse testing in exhaled breath
-
Ion mobility spectrometry for detection of Cannabis sativa L. metabolites from exhaled breath
-
Î9-Tetrahydrocannabinol concentrations in exhaled breath and physiological effects following cannabis intake â a pilot study using illicit cannabis
DRUG TESTING-EDIBLES (3)
-
Simultaneous determination of delta-9-tetrahydrocannabinol cannabidiol and cannabinol in edible oil using ultra performance liquid chromatography-tandem mass spectrometry
-
Simultaneous Analysis of Cannabinoid and Synthetic Cannabinoids in Dietary Supplements Using UPLC with UV and UPLC-MS-MS
-
Stability of Tetrahydrocannabinol and Cannabidiol in Prepared Quality Control Medible Brownies
DRUG TESTING-HAIR (44)
-
Hair analysis for Delta9-tetrahydrocannabinolic acid A â new insights into the mechanism of drug incorporation of cannabinoids into hair
-
11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid ethyl ester (THC-COOEt): unsuccessful search for a marker of combined cannabis and alcohol consumption
-
A study on the concentrations of 11-nor-Î(9)-tetrahydrocannabinol-9-carboxylic acid (THCCOOH) in hair root and whole hair
-
A comparative study on the concentrations of 11-nor-Î(9)-tetrahydrocannabinol-9-carboxylic acid (THCCOOH) in head and pubic hair
-
Detection and quantification of 11-nor-Î9-tetrahydrocannabinol-9-carboxylic acid in hair by GC/MS/MS in Negative Chemical Ionization mode (NCI) with a simple and rapid liquid/liquid extraction
-
The standardization of results on hair testing for drugs of abuse: An inter-laboratory exercise in Lombardy Region, Italy
-
Determination of 22 synthetic cannabinoids in human hair by liquid chromatography tandem mass spectrometry
-
Simultaneous analysis of several synthetic cannabinoids, THC, CBD and CBN, in hair by ultra-high performance liquid chromatography tandem mass spectrometry. Method validation and application to real samples
-
Monitoring of chronic Cannabis abuse: An LC-MS/MS method for hair analysis
-
Development and validation of an LC-MS/MS method for quantification of Î9-tetrahydrocannabinolic acid A (THCA-A), THC, CBN and CBD in hair
-
Determination of cocaine, cocaine metabolites and cannabinoids in single hairs by MALDI Fourier transform mass spectrometry â preliminary results
-
Deposition of JWH-018, JWH-073 and their metabolites in hair and effect of hair pigmentation
-
Diagnostic Value of Concentration Profiles of Glucocorticosteroids and Endocannabinoids in Hair
-
Methadone and illegal drugs in hair from children with parents in maintenance treatment or suspected for drug abuse in a German community
-
Screening for synthetic cannabinoids in hair by using LC-QTOF MS: A new and powerful approach to study the penetration of these new psychoactive substances in the population
-
Hair analysis for THCA-A, THC and CBN after passive in vivo exposure to marijuana smoke
-
Utility of ELISA screening for the monitoring of abstinence from illegal and legal drugs in hair and urine
-
Utility of coloured hair for the detection of drugs and alcohol
-
Pediatric exposure to drugs of abuse by hair testing: monitoring 15 years of evolution in Spain
-
Hair-based rapid analyses for multiple drugs in forensics and doping: application of dynamic multiple reaction monitoring with LC-MS/MS
-
Cannabinoid findings in children hair â what do they really tell us? An assessment in the light of three different analytical methods with focus on interpretation of Î9-tetrahydrocannabinolic acid A concentrations
-
Proof of cannabis administration by sensitive detection of 11-nor-Delta(9)-tetrahydrocannabinol-9-carboxylic acid in hair using selective methylation and application of liquid chromatography- tandem and multistage mass spectrometry
-
Workplace drug testing in Italy: Findings about second-stage testing
-
Simultaneous determination of five naphthoylindole-based synthetic cannabinoids and metabolites and their deposition in human and rat hair
-
Contribution of in utero drug exposure when interpreting hair results in young children
-
Hair analysis as a tool to evaluate the prevalence of synthetic cannabinoids in different populations of drug consumers
-
Ultra-structural hair alterations of drug abusers: a scanning electron microscopic investigation
-
Hair analysis for Î(9) -tetrahydrocannabinolic acid A (THCA-A) and Î(9) -tetrahydrocannabinol (THC) after handling cannabis plant material
-
Finding cannabinoids in hair does not prove cannabis consumption
-
Determination of XLR-11 and its metabolites in hair by liquid chromatography-tandem mass spectrometry
-
Comparison of cannabinoids in hair with self-reported cannabis consumption in heavy, light and non-cannabis users
-
Assessment of rates of recanting and hair testing as a biological measure of drug use in a general population sample of young people
-
Evidence based decontamination protocols for the removal of external Î9-tetrahydrocannabinol (THC) from contaminated hair
-
Metabolites of synthetic cannabinoids in hair-proof of consumption or false friends for interpretation?
-
Endocannabinoid concentrations in hair are associated with PTSD symptom severity
-
Influence of thermal hair straightening on cannabis and cocaine content in hair
-
Techniques and technologies for the bioanalysis of Sativex®, metabolites and related compounds
-
Highly sensitive quantification of unconjugated 11-nor-9-carboxy-Î9- tetrahydrocannabinol in a cannabis userâs hair using micropulverized extraction
-
Contactless decontamination of hair samples: cannabinoids
-
Simultaneous HPLC-APCI-MS/MS quantification of endogenous cannabinoids and glucocorticoids in hair
-
Detection and Mapping of Cannabinoids in single hair samples through rapid derivatization- Matrix-Assisted Laser Desorption Ionization Mass Spectrometry
-
A systematic review of passive exposure to cannabis
-
Comparative Evaluation of Drug Deposition in Hair Samples Collected from Different Anatomical Body Sites
-
Drugs in hair. Part I. Metabolisms of major drug classes
DRUG TESTING-ORAL (52)
-
Patent 7816143 Oral detection test for cannabinoid use
-
Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry
-
Direct detection of Delta9-tetrahydrocannabinol in saliva using a novel homogeneous competitive immunoassay with fluorescence quenching
-
Oral Fluid and Plasma Cannabinoid Ratios after Around-the-Clock Controlled Oral [Delta]9-Tetrahydrocannabinol Administration
-
Synthetic cannabinoids in oral fluid
-
Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-the-clock oral THC administration
-
Cannabinoids in oral fluid following passive exposure to marijuana smoke
-
Oral Fluid Cannabinoids in Chronic, Daily Cannabis Smokers During Sustained, Monitored Abstinence
-
US Patent Application 20110020945 â ORAL DETECTION TEST FOR CANNABINOID USE
-
A validated method for the detection and quantitation of 50 drugs of abuse and medicinal drugs in oral fluid by gas chromatography-mass spectrometry
-
A placebo-controlled study to assess Standardized Field Sobriety Tests performance during alcohol and cannabis intoxication in heavy cannabis users and accuracy of point of collection testing devices for detecting THC in oral fluid
-
Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?
-
Endocannabinoids measurement in human saliva as potential biomarker of obesity
-
Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis
-
Ultra high performance liquid chromatography-electrospray ionization-tandem mass spectrometry screening method for direct analysis of designer drugs, âspiceâ and stimulants in oral fluid
-
Influence of Ethanol on the Pharmacokinetic Properties of Î9-Tetrahydrocannabinol in Oral Fluid
-
Current knowledge on cannabinoids in oral fluid
-
11-Nor-9-carboxy-â9-tetrahydrocannabinol quantification in human oral fluid by liquid chromatography-tandem mass spectrometry
-
Oral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration
-
Oral Fluid Cannabinoids in Chronic Cannabis Smokers during Oral Î9-Tetrahydrocannabinol Therapy and Smoked Cannabis Challenge
-
Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers
-
Detection of Synthetic Cannabinoids in Oral Fluid Using ELISA and LC-MS-MS
-
Detection of Synthetic Cannabinoids in Oral Fluid Using ELISA and LC-MS-MS
-
Comparison between self-report of cannabis use and toxicological detection of THC/THCCOOH in blood and THC in oral fluid in drivers in a roadside survey
-
Driving Under the Influence of Cannabis: Pitfalls, Validation, and Quality Control of a UPLC-MS/MS Method for the Quantification of Tetrahydrocannabinol in Oral Fluid Collected With StatSure, Quantisal, or Certus Collector
-
LC/ESI-MS/MS method for quantification of 28 synthetic cannabinoids in neat oral fluid and its application to preliminary studies on their detection windows
-
Micro extraction by packed sorbent coupled to liquid chromatography tandem mass spectrometry for the rapid and sensitive determination of cannabinoids in oral fluids
-
Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint